Visceral Adiposity Index
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To individuate a novel sex-specific index, based on waist circumference, BMI, triglycerides, and HDL cholesterol, indirectly expressing visceral fat function. RESEARCH DESIGN AND METHODS: Visceral adiposity index (VAI) was first modeled on 315 nonobese healthy subjects. Using two multiple logistic regression models, VAI was retrospectively validated in 1,498 primary care patients in comparison to classical cardio- and cerebrovascular risk factors. RESULTS: All components of metabolic syndrome increased significantly across VAI quintiles. VAI was independently associated with both cardiovascular (odd ratio [OR] 2.45; 95% CI 1.52–3.95; P < 0.001) and cerebrovascular (1.63; 1.06–2.50; P = 0.025) events. VAI also showed significant inverse correlation with insulin sensitivity during euglycemic-hyperinsulinemic clamp in a subgroup of patients (Rs = −0.721; P < 0.001). By contrast, no correlations were found for waist circumference and BMI. CONCLUSIONS: Our study suggests VAI is a valuable indicator of “visceral adipose function” and insulin sensitivity, and its increase is strongly associated with cardiometabolic risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“increased fat mass is associated with elevated adipocytokine and proinflammatory cytokines, insulin resistance, increased risk of developing adverse outcomes of diabetes, hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis, and a higher mortality rate [10].”
From Trend of various adiposity indices in women with and without history of gestational diabetes: a population-based cohort study (2019) · cites this paper as [10]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pouliot, M.-C., Després, J.-P., Lemieux, S., Moorjani, S., Bouchard, C., Tremblay, A., Nadeau, A., & Lupien, P. J. (1994) · The American Journal of Cardiology · doi:10.1016/0002-9149(94)90676-9 · Cited by 2,085
Ohlson, L. O., Larsson, B., Svärdsudd, K., Welin, L., Eriksson, H., Wilhelmsen, L., Björntorp, P., & Tibblin, G. (1985) · Diabetes · doi:10.2337/diab.34.10.1055 · Cited by 1,020
Unger, R. H. (2003) · Endocrinology · doi:10.1210/en.2003-0870 · Cited by 677 · cited 1×
“Indeed, this condition characterized by visceral obesity and “high-triglyceride/low–HDL cholesterol dyslipidemia” has been associated with physiological age-linked leptin resistance, muscle, and liver insulin resistance, lipotoxic cardiomyopathy, and generalized endothelial dysfunction (15).”
BackgroundIs visceral obesity the cause of the metabolic syndrome?
Després, J. (2006) · Annals of Medicine · doi:10.1080/07853890500383895 · Cited by 651
Age-related inflammatory cytokines and disease
Brüünsgaard, H., & Pedersen, B. K. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(02)00056-5 · Cited by 608 · cited 1×
“V isceral obesity (1) is associated with increased adipocytokine production, proinflammatory activity (2), deterioration of insulin sensitivity (3), increased risk of developing diabetes, “high-triglyceride/low–HDL cholesterol dyslipidemia,” hypertension, atherosclerosis, and higher mortality rate (4–7).”
BackgroundSubdivisions of subcutaneous abdominal adipose tissue and insulin resistance
Kelley, D. E., Thaete, F. L., Troost, F., Huwe, T., & Goodpaster, B. H. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.278.5.e941 · Cited by 538
Body fat distribution, insulin resistance, and metabolic diseases
Björntorp, P. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00191-3 · Cited by 470
High Visceral and Low Abdominal Subcutaneous Fat Stores in the Obese Adolescent
Taksali, S. E., Caprio, S., Dziura, J., Dufour, S., Calí, A. M. G., Goodman, T. R., Papademetris, X., Burgert, T. S., Pierpont, B. M., Savoye, M., et al. (2008) · Diabetes · doi:10.2337/db07-0932 · Cited by 353
Rader, D. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.01.003 · Cited by 346
Visceral Fat in Hypertension: Influence on Insulin Resistance and β-Cell Function
Sironi, A. M., Gastaldelli, A., Mari, A., Ciociaro, D., Postano, V., Buzzigoli, E., Ghione, S., Turchi, S., Lombardi, M., & Ferrannini, E. (2004) · Hypertension · doi:10.1161/01.hyp.0000137982.10191.0a · Cited by 268
Research works printed but not linked: 1
- De Fronzo, 1979, The glucose clamp technique: a method for the quantification of beta cell sensitivity to glucose and of tissue sensitivity to insulin, Am J Physiol, 237, 214
Cited by
Items 801–900 of 1,005
Li, B., Wang, W., Gao, Z., Tang, X., Yan, L., Wan, Q., Luo, Z., Qin, G., Chen, L., Ning, G., et al. (2022) · Journal of Diabetes · doi:10.1111/1753-0407.13336 · Cited by 12
“Therefore, a practical, user-friendly, and relatively accurate method for evaluating visceral adiposity mass is urgently required.(18) Traditional anthropometric measures, such as body mass index (BMI), waist circumference (WC), and waistto-hip ratio (WHR), have the general disadvantage that they do not take into acco…”
MethodÍndice de adiposidade visceral como preditor de risco cardiometabólico em crianças e adolescentes
Oliveira, R. P., Remor, J. M., Matsuo, A. R., Dada, R. P., Mendes, A. A., dos Santos, T. L. C., Locatelli, J. C., Terra, C. M. D. O., Lazarin, S. P. B., & Nardo, N. (2017) · Revista Brasileira de Medicina do Esporte · doi:10.1590/1517-869220172303172626 · Cited by 12
Docherty, P. D. (2011) · UC Research Repository (University of Canterbury) · doi:10.26021/2487 · Cited by 12
Yu, L., Li, Y., Ma, R., Guo, H., Zhang, X., Yan, Y., He, J., Wang, X., Niu, Q., & Guo, S. (2022) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s352401 · Cited by 11
Hewage, N., Wijesekara, U., & Perera, R. (2024) · Endocrinology and Metabolism · doi:10.3803/enm.2024.2015 · Cited by 11
The Effect of Exercise on Spexin and Follistatin in Elderly Individuals
Ayaz, E. Y., Dinçer, B., Cinbaz, G., Karacan, E., Benli, R. K., Mete, E., Bilgiç, H., & Mesçi, B. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13692 · Cited by 11
Lajeunesse‐Trempe, F., Dugas, S., Maltais‐Payette, I., Tremblay, È.-J., Piché, M., Dimitriadis, G. K., Lafortune, A., Marceau, S., Biertho, L. D., & Tchernof, A. (2025) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/cjgh/5545227 · Cited by 11
Tang, M., Li, Y., Chen, Z., & Yang, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-08138-4 · Cited by 11
Wani, K., Emam, O., Kumar, B., Al‐Daghri, N. M., & Sabico, S. (2025) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-025-01836-z · Cited by 11
Loureiro, L. M., Lessa, S., Mendes, R., Pereira, S., Saboya, C. J., & Ramalho, A. (2019) · Nutrients · doi:10.3390/nu11092125 · Cited by 11
de Oliveira, C. M., da Rosa, F. F., Alvim, R. D. O., Júnior, C. A. M., Bacells, M., Liu, C., Pavani, J., Capasso, R., Dias, F. A. L., Krieger, J. E., et al. (2022) · Journal of Clinical Hypertension · doi:10.1111/jch.14480 · Cited by 11
Wang, Q., Zhang, L., Li, Y., Tang, X., Yao, Y., & Fang, Q. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.1036215 · Cited by 11
“, 1996), VAI (Amato et al., 2010), and CVAI (Xia et al.”
BackgroundWang, S., Zhang, W. S., Jiang, C. Q., Jin, Y. L., Zhu, T., Zhu, F., & Xu, L. (2023) · BMC Cancer · doi:10.1186/s12885-023-10762-0 · Cited by 11
Elmas, H., Duran, C., Can, M., Tolu, İ., & Güney, İ. (2023) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0043-1764497 · Cited by 11
Thomas, T. S., Dunderdale, C. N., Lu, M. T., Walpert, A. R., Shen, G., Young, M. C. H., Torriani, M., Chu, J. T., Haptu, H. H., Manandhar, M., et al. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad398 · Cited by 11
Weyman-Vela, Y., Guerrero‐Romero, F., & Simental‐Mendía, L. E. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02201-5 · Cited by 11
Zuo, L., Lin, J., Ge, S., Wu, R., Liu, B., Cheng, Y., & Tian, Y. (2024) · Oncology Letters · doi:10.3892/ol.2024.14233 · Cited by 11
Takhttavous, A., Saberi‐Karimian, M., Hafezi, S. G., Esmaily, H., Hosseini, M., Ferns, G. A., Amirfakhrian, E., Ghamsary, M. G., Ghayour‐Mobarhan, M., & Alinezhad‐Namaghi, M. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02006-2 · Cited by 11
Rocha, A. L. L., Baêta, T., Nazareth, I. R., Costa, J. M., Caporalli, J. D., Oliveira, M. A., Couto, M. G., Azevedo, R. C., Comim, F. V., Oliveira, F. R., et al. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-023-07328-7 · Cited by 11
Cheng, Z., Hu, C., Zhang, Y., Zhou, J., Shi, J., Sun, L., & Chen, Z. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s469859 · Cited by 11
Associations Between Sensitivity to Thyroid Hormones and Visceral Adiposity in Euthyroid Adults
Wei, Y., Yang, M., Liu, J., Wang, Y., & Wang, G. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae806 · Cited by 11
Hjorth, P., Espensen, C. H., Madsen, N. J., Viuff, A. G., & Munk‐Jørgensen, P. (2018) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000278 · Cited by 11
Chin, Y., Lin, W., Wu, P., Tsai, S., Lee, C., Seal, D. W., Chen, T., Huang, H., & Lee, C. (2020) · Nutrients · doi:10.3390/nu12103165 · Cited by 11
“In insulin and fat function studies, triglyceride-glucose index (TGI) was used as a surrogate for identifying insulin resistance among healthy subjects [17], and visceral adiposity index (VAI) was identified as an indicator of visceral adipose function and insulin sensitivity [18].”
Zaki, M. E., Amin, D. H., & Mohamed, R. (2020) · Journal of Complementary and Integrative Medicine · doi:10.1515/jcim-2020-0073 · Cited by 11
Aşçı, R., Bolat, M. S., Dündar, C., ÖZDEMİR, A. Z., & Atmaca, A. A. (2021) · International Journal of Clinical Practice · doi:10.1111/ijcp.14611 · Cited by 11
Craniopharyngioma, Chronotypes and Metabolic Risk Profile
Somma, C. D., Scarano, E., Barrea, L., Solari, D., Riccio, E., Arianna, R., Cavallo, L. M., Romano, F., Benedetto, E. D., Rodriguez, A., et al. (2021) · Nutrients · doi:10.3390/nu13103444 · Cited by 11
“[52] in which patients with CP, both adults and children, showed increased values of the Visceral Adiposity Index, a surrogate marker of cardiovascular risk [53].”
Backgrounddos Santos, J. L., Portal, V. L., Markoski, M. M., de Quadros, A. S., Bersch-Ferreira, Â. C., & Marcadenti, A. (2021) · European Journal of Clinical Nutrition · doi:10.1038/s41430-021-01045-7 · Cited by 11
Karamfilova, V., Assyov, Y. S., Nedeva, I., Gateva, A., Ivanova, I. D., Cherkezov, N., Mateva, L., & Kamenov, Z. A. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.201165 · Cited by 11
Correia, E. S., Godinho-Mota, J. C. M., Schincaglia, R. M., Martins, K. A., Martins, J. S., Vilella, P. R., Soares, L. R., & Vaz-Gonçalves, L. (2022) · Clinical Nutrition Open Science · doi:10.1016/j.nutos.2022.01.001 · Cited by 11
de Medeiros, S. F., Barbosa, B. B., de Medeiros, M. A. S., Yamamoto, A. K. L. W., & Yamamoto, M. M. W. (2022) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1055/s-0041-1741030 · Cited by 11
Ataee, Z., Aghaee, A., Sobhani, S. R., Miandehi, E. E., Pirzadeh, P., Alinezhad‐Namaghi, M., Eslami, S., & Sobhani, S. (2023) · International Journal of Hypertension · doi:10.1155/2023/2180923 · Cited by 11
Barik, A., Shah, R. V., Spahillari, A., Murthy, V. L., Ambale‐Venkatesh, B., Kumar, R., Das, K., Santra, A. K., Hembram, J. R., Bhattacharya, D. K., et al. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.09.120 · Cited by 11
Faramarzi, M., Bagheri, L., & Banitalebi, E. (2018) · Isokinetics and Exercise Science · doi:10.3233/ies-172195 · Cited by 11
“VAI is a simple mathematical relation based on gender-specific anthropometric models (WC, BMI) and functional parameters (triglyceride and HDL cholesterol) which shows body fat distribution and its function [7].”
Serretta, V., Abrate, A., Siracusano, S., Gesolfo, C. S., Vella, M., Maida, F. D., Cangemi, A. G., Cicero, G., Barresi, E., & Sanfilippo, C. (2018) · Urology Annals · doi:10.4103/ua.ua_188_17 · Cited by 11
“Visceral adiposity index (VAI) is a sex‐specific obesity index, based on WC, BMI, plasmatic triglycerides (TG), and high‐density lipoproteins (HDL), evaluating more accurately the dysfunction of visceral adipose tissue.[21] The endocrine activity of visceral fat might play a carcinogenetic role increasing circulating…”
BackgroundMethodInfluentialRashid, N., Nigam, A., Kauser, S., Prakash, P., Jain, S. K., & Wajid, S. (2020) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2020.1724157 · Cited by 11
“VAI¼ [WC/36.58þ(1.89 BMI)] (TG/0.81) (1.52/HDL) where TG and HDL concentration were expressed in mmol/L (Amato et al. 2010).”
BackgroundInfluentialPeningkatan visceral adiposity index berhubungan dengan sindrom metabolik remaja obesitas
Dieny, F. F., Jauharany, F. F., Tsani, A. F. A., & Fitranti, D. Y. (2020) · Jurnal Gizi Klinik Indonesia · doi:10.22146/ijcn.51465 · Cited by 11
Association of adiposity with diabetes: A national research among Chinese adults
Fu, W., Wang, C., Zou, L., Jiang, H., Miller, M., Gan, Y., Cao, S., Xu, H., Mao, J., Yan, S., et al. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3380 · Cited by 11
Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes
Khorlampenko, A. A., Каретникова, В. Н., Kochergina, A. M., Ignatova, Y. S., Belik, E. V., Gruzdeva, O. V., Brel, N. K., Коков, А. Н., & Барбараш, О. Л. (2020) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2020-2311 · Cited by 11
Freitas, A. T. A., Giraldo, A. E. D., Rezende, G. P., Yela, D. A., Jales, R. M., & Benetti‐Pinto, C. L. (2020) · Clinical Endocrinology · doi:10.1111/cen.14331 · Cited by 11
Haider, K. S., Haider, A., Doros, G. D., & Saad, F. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0011 · Cited by 11
Jalali, M., Bahadoran, Z., Mirmiran, P., Azizi, F., & Hosseinpanah, F. (2024) · BMC Public Health · doi:10.1186/s12889-023-17381-1 · Cited by 10
Liu, W., Song, S., Zhang, H., & An, C. (2024) · Scientific Reports · doi:10.1038/s41598-024-81191-7 · Cited by 10
Chang, K., Li, B., Wang, G., Zhou, H., Chen, Y., & Gu, H. (2025) · BMC Urology · doi:10.1186/s12894-025-01698-7 · Cited by 10
Fang, Z., Yuan, J. J., Qiu, J., Liu, Q., He, R., Zheng, D., Jin, J., & He, Q. (2025) · Cardiorenal Medicine · doi:10.1159/000547533 · Cited by 11
Metabolic and hepatic biomarkers associated with MASLD in the Chinese population
Chen, H., Chen, Z., Bai, X., Li, Z., Huang, S., Li, J., Li, J., Wang, Y., Han, L., Xia, K., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-17219-3 · Cited by 10
Wang, Y., Wang, H., Liu, X., & Zhang, J. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01762-6 · Cited by 10
Cosma, T., Avram, L., Donca, V., Grosu, A. I., Stoicescu, L., Buzdugan, E., Nemeș, A., Bălan, A. M., & Crișan, D. (2025) · Nutrients · doi:10.3390/nu17243940 · Cited by 10
“VAI was selected because it was the most appropriate index given the biological and anthropometric parameters available in our cohort (BMI, waist circumference, triglycerides, HDL-C), and it is a validated marker of adipose tissue dysfunction in comparable populations [22].”
Kunutsor, S. K., Bhattacharjee, A., Jae, S. Y., & Laukkanen, J. A. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104475 · Cited by 10
Palmeiro-Silva, Y. K., Aravena, R. I., Ossio, L., & Fluxá, J. P. (2020) · Nutrients · doi:10.3390/nu12082392 · Cited by 10
Yang, Q., Liu, Y., Jin, Z., Liu, L., Yuan, Z., Xu, D., & Hong, F. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265228 · Cited by 10
“In 2010, Amato proposed that VAI can be used in daily clinical practice and population studies to assess the cardiometabolic risk associated with visceral obesity [13].”
BackgroundInfluentialda Silva, B. R., Rufato, S., Mialich, M. S., Cruz, L. P., Gozzo, T. D. O., & Jordão, A. A. (2022) · Nutrition and Cancer · doi:10.1080/01635581.2022.2093388 · Cited by 10
Yazdanpanah, Z., Salehi‐Abargouei, A., Mollahosseini, M., Sheikhha, M. H., Mirzaei, M., & Mozaffari–Khosravi, H. (2023) · British Journal Of Nutrition · doi:10.1017/s0007114523000570 · Cited by 10
Yang, Q., Wang, X., Li, C., & Wang, X. (2023) · Scientific Reports · doi:10.1038/s41598-023-33082-6 · Cited by 10
Vitamin D Inadequacy and Its Relation to Body Fat and Muscle Mass in Adult Women of Childbearing Age
Magalhães, P. M., da Cruz, S. P., Carneiro, O. A., Teixeira, M. T., & Ramalho, A. (2024) · Nutrients · doi:10.3390/nu16091267 · Cited by 10
“…and body fat, BMI [26], waist-to-hip ratio (WHR) [30], conicity index (CI) [31], waist-to-height ratio (WHtR) [32], visceral adiposity index (VAI) [33], body adiposity index (BAI) [34], a body shape index (ABSI) [35], Clinical Universidad Navarre—body adiposity estimator (CUN-BAE) [36], and…”
BackgroundYang, C., Chen, S., Feng, B., Lu, Y., Wang, Y., Liao, W., Wu, S., & Wang, L. (2024) · Maturitas · doi:10.1016/j.maturitas.2024.108148 · Cited by 10
Yan, S., Chai, K., Yang, J., & Wang, H. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02410-8 · Cited by 10
Wu, M., Lai, W., Huo, X., Wang, Q., Zhou, Y., & Gao, D. (2025) · BMC Cardiovascular Disorders · doi:10.1186/s12872-025-04591-1 · Cited by 10
Abolhasani, M., Maghbouli, N., Sazgara, F., Saleh, S. K., Tahmasebi, M., & Ashraf, H. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s254741 · Cited by 10
Xu, C. B., Zhao, S., Yu, S., Chi, C., Fan, X., Ji, H., Maimaitiaili, R., Teliewubai, J., Li, X., Zhang, Y., et al. (2020) · Aging Clinical and Experimental Research · doi:10.1007/s40520-020-01752-4 · Cited by 10
Visceral Adiposity Index in Breast Cancer Survivors: A Case-Control Study
Cardoso‐Peña, E., Piña, A. E. S., Gómez‐Villanueva, Á., Chavez, G. E. L., Martínez, P. R., Ramírez-Montoya, H., Berumen-Lechuga, M. G., Benitez-Arciniega, A. D., Fortepiani, M. L. A., Valdés‐Ramos, R., et al. (2020) · International Journal of Endocrinology · doi:10.1155/2020/8874916 · Cited by 10
Mazzutti, F. S., Custódio, I. D. D., Lima, M. T. M., de Carvalho, K. P., Pereira, T. S. S., Molina, M. D. C. B., Canto, P. P. L., Paiva, C. E., & Maia, Y. C. D. P. (2021) · Nutrients · doi:10.3390/nu13041114 · Cited by 10
Xu, K., Shi, L. S., Zhang, B., Mi, B., Yang, J., Sun, X., Liao, X., Dai, X., Zeng, L., Liu, X., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.03.025 · Cited by 10
Raeisi‐Dehkordi, H., Amiri, M., Moghtaderi, F., Zimorovat, A., Rahmanian, M., Mozaffari–Khosravi, H., & Salehi‐Abargouei, A. (2021) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.11265 · Cited by 10
Min, J., Hu, X., Zhang, J., Zeng, T., Wang, Y., Tian, S., Liu, G., Zhong, X., Qiu, K., Peng, M., et al. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s313475 · Cited by 10
Osteoprotegerin expression and serum values in obese women with type 2 diabetes mellitus
Rashad, N. M., El‐Shal, A. S., Shalaby, S. M., Abdelnour, H. M., & Sarhan, W. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06699-x · Cited by 10
Calcaterra, V., Verduci, E., SILVESTRI, A. D., Magenes, V. C., Siccardo, F., Schneider, L. A., Vizzuso, S., Bosetti, A., & Zuccotti, G. (2021) · Children · doi:10.3390/children8110966 · Cited by 10
Abolhasani, M., Maghbouli, N., Saleh, S. K., Aghsaeifar, Z., Sazgara, F., Tahmasebi, M., Ashraf, H., & Haidar, J. (2021) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s340664 · Cited by 10
Moghtaderi, F., Amiri, M., Raeisi‐Dehkordi, H., Zimorovat, A., Mohyadini, M., & Salehi‐Abargouei, A. (2022) · Phytotherapy Research · doi:10.1002/ptr.7381 · Cited by 10
Bagheri, A., Khosravy, T., Moradinazar, M., Nachvak, S. M., Pasdar, Y., Soleimani, D., & Samadi, M. (2022) · Food Science & Nutrition · doi:10.1002/fsn3.2874 · Cited by 10
“…and visceral adipose tissue in the development of insulin resistance (Amato et al., 2010; Ciresi et al., 2017), T2DM (Janghorbani & Amini, 2016), inflammation (Amato & Giordano, 2014, Amato et al., 2014), and metabolic syndrome (Amato et al., 2010), suggest that VAI was an assessment tool for T2DM.”
BackgroundMethodInfluentialMartínez‐Sánchez, F. D., Diaz-Jarquin, A., Vargas-Abonce, V. P., Torres-Cuevas, J. L., Guerrero-Castillo, A. P., Medina‐Julio, D., Meza-Arana, C. E., Gulías-Herrero, A., & Gómez-Sámano, M. Á. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100091 · Cited by 10
Song, D., Ge, Q., Chen, M., Bai, S., Lai, X., Huang, G., Liu, M., Lin, M., Xu, J., & Dong, F. (2022) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2021.00317 · Cited by 10
Visceral adiposity indices and cardiometabolic risk markers in patients with hypertension
Sena, B. D. S., Gonçalves, F. C. L. D. S. P., Maio, R., Silva, R. P. P., de Lemos, M. D. C. C., & de Arruda, I. K. G. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000536 · Cited by 10
“Previous studies have argued for LAP (8) and VAI (9) as indices with a potential to predict lipid accumulation and visceral fat function associated with adverse cardiovascular and metabolic outcomes, as well as significant association of LAP with increased risk of AH (10) and a positive…”
BackgroundShen, S., Huang, H., Wang, J., Tang, Z., Shen, C., & Xu, C. (2022) · Digestive Diseases and Sciences · doi:10.1007/s10620-022-07787-z · Cited by 10
Wang, H., Cao, H., Cao, J., & Zhang, L. (2023) · BioMed Research International · doi:10.1155/2023/1508675 · Cited by 10
RetractedHuang, Y., Huang, J., Chien, H., Lin, C.-I., Chuang, Y., Cheng, H., Lin, W.-T., Lin, Y., Chuang, H., Ho, C.-K., et al. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.08.005 · Cited by 10
Mitochondrial DNA copy number in adults with and without Type 1 diabetes
Jenkins, A. J., Carroll, L. M., Huang, M., Loh, Y. W., Mangani, A., O'Neal, D. N., & Januszewski, A. S. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110877 · Cited by 10
“[23] and our validated formula [24,25] based on routinely available clinical and laboratory data including age, waist circumference, HDL-C, HbA1c, eGFR, Visceral Adiposity Index [26], pulse pressure and diagnosis of hypertension.”
Kumpatla, S., Michael, C., & Viswanathan, V. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.05.003 · Cited by 10
Predictors of Hypertension among Adult Tribal Males of India
Kapoor, A. (2014) · International Journal of TROPICAL DISEASE & Health · doi:10.9734/ijtdh/2012/1750 · Cited by 10
Metabolic syndrome in retired soccer players: A pilot study
Panayiotoglou, A., Grammatikopoulou, M. G., Maraki, M. I., Chourdakis, M., Gkiouras, K., Theodoridis, X., Papadopoulou, S. Κ., Famisis, K., & Hassapidou, M. N. (2017) · Obesity Medicine · doi:10.1016/j.obmed.2017.09.004 · Cited by 10
“Additionally, Visceral adiposity Index (VAI) (Amato et al., 2010), was computed for all participants, as VAI ¼ [WC/ 39.68þ(1.88 BMI)] (TG/1.03) (1.52/HDL-C).”
InfluentialPasdar, Y., Hamzeh, B., Najafi, F., & Darbandi, M. (2019) · Mediterranean Journal of Nutrition and Metabolism · doi:10.3233/mnm-190324 · Cited by 10
“The BF% can be useful in assessing the risk of the MetS [9–11].”
Sterling, R. K., King, W. C., Khalili, M., Kleiner, D. E., Hinerman, A. S., Sulkowski, M., Chung, R. T., Jain, M. K., Lisker‐Melman, M., Wong, D., et al. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06860-3 · Cited by 10
Kamrul-Hasan, A. B. M., & Aalpona, F. T. Z. (2021) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_119_21 · Cited by 10
Kaneva, A. M., & Bojko, E. R. (2022) · Health Risk Analysis · doi:10.21668/health.risk/2022.3.15 · Cited by 10
Leveraging the future of diagnosis and management of diabetes: From old indexes to new technologies
Meneses, M. J., Patarrão, R. S., Pinheiro, T., Coelho, I., Carriço, N., Marques, A. C., Romão, A., Nabais, J. M. V., Fortunato, E. M. C., Raposo, J. F., et al. (2022) · European Journal of Clinical Investigation · doi:10.1111/eci.13934 · Cited by 10
Vitamin A Deficiency and Its Association with Visceral Adiposity in Women
Góes, É., Cordeiro, A., Bento, C., & Ramalho, A. (2023) · Biomedicines · doi:10.3390/biomedicines11030991 · Cited by 10
“52 ÷ HDL-c) for women, where TG and high-density lipoprotein cholesterol (HDL-c) are expressed in mmol/L, with a cut-off point >1 [24].”
BackgroundIsmail, N. A., Ragab, S. H., ElBaky, A. A., & Ibrahim, M. H. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.698 · Cited by 10
“TG, and HDL-C levels are expressed in mmol/L, and WC in expressed in cm [9], [13].”
BackgroundNovel gender-specific visceral adiposity index for Mexican pediatric population
Garcés-Hernández, M. J., Hernández-Ruiz, J., Queipo, G., Klünder‐Klünder, M., Bustos, M., Herrera, A., López-Alvarenga, J. C., Quispe-Siccha, R. M., Espinosa, A., & Garibay-Nieto, N. (2014) · Revista Médica Del Hospital General De México · doi:10.1016/j.hgmx.2014.10.002 · Cited by 10
Yan, Z., Chang, X., Liu, Z., Liu, R., & Du, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1492082 · Cited by 9
“Previous research, including that by Marco C, identi fi ed VAI as an important indicator of visceral fat function and insulin sensitivity (38).”
Liu, D., Lv, X., Li, W., Dai, H., Tan, Y., Yang, D., & Zhang, X. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1621074 · Cited by 9
Parsaei, M., Karimi, E., Barkhordarioon, A., Yousefi, M., & Tarafdari, A. (2025) · Lipids in Health and Disease · doi:10.1186/s12944-025-02719-y · Cited by 9
Li, X., Maimaiti, A., Ling, Y., Wan, Y., Cui, H., Tao, Z., Zhang, Z., Wu, Y., Zhao, G., & Zaid, M. (2025) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.70109 · Cited by 9
Wang, T., Zhang, L., Chen, P., Chen, C., Xu, L., & Guo, M. (2025) · BMC Public Health · doi:10.1186/s12889-025-25830-2 · Cited by 9
Kunutsor, S. K., Jae, S. Y., & Laukkanen, J. A. (2025) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2025.09.021 · Cited by 9
Paternò, V., Geraci, G., Piticchio, T., Moli, R. L., Burgio, S., Costanzo, G., Sambataro, G., Baratta, R., Barbagallo, F., & Pallotti, F. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1700894 · Cited by 9
“The VAI is a composite measure that captures both body fat distribution and lipid pro fi le, offering a practical proxy that summarizes function and distribution of adipose tissue, which has been demonstrated to predict the risk of cardiometabolic disease (25).”
Braha, A., Albai, A., Timar, B., Cipu, D., Vasiluță, L., Potre, O., & Timar, R. Z. (2021) · Medicina · doi:10.3390/medicina58010021 · Cited by 9
Alfawaz, H., Khan, N., Ansari, M. G. A., Khattak, M. N. K., Saadawy, G. M., & Al‐Daghri, N. M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12237280 · Cited by 9
“…> 85 mmHg and/or systolic BP > 130 mmHg. Adiposity index calculations: (a) The LAP index [20] was computed based on the following equations among males and females, respectively: In Males, LAP = { WC ( cm ) − 65 } ∗ TG ( mmol l ) In Females, LAP = { WC ( cm ) − 58 } ∗ TG ( mmol l ) (b) VAI [19] In”
BackgroundMethodCardiometabolic risk assessment: A school-based study in Brazilian adolescent
Braga, R. A. M., Bezerra, I. N., Nogueira, M. D. D. A., Souza, A. D. M., Martins, G. D. S., Almondes, K. G. D. S., Moreno, L. A., & Maia, C. S. C. (2023) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2023.12.016 · Cited by 9
Barbagallo, F., Tiranini, L., Placentino, C., Mariacci, G., Piccinino, M., Cucinella, L., Calogero, A. E., & Nappi, R. E. (2024) · Children · doi:10.3390/children11050521 · Cited by 9
Lai, X., & Chen, T. (2024) · Scientific Reports · doi:10.1038/s41598-024-69226-5 · Cited by 9
Deng, X., Ma, L., Li, P., He, M., Jin, R., Tao, Y., Cao, H., Gao, H., Zhou, W., Lu, K., et al. (2024) · Lipids in Health and Disease · doi:10.1186/s12944-024-02384-7 · Cited by 9
Metadata
- Authors
- Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A., & for the AlkaMeSy Study Group
- Affiliations
- University of Palermo (IT)
- Corresponding author
- Galluzzo, Aldo
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-01-12
- Volume
- 33
- Issue
- 4
- Pages
- 920-922
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2845052
- OpenAlex
- W2125944762
- Cited by
- 1,751
- References
- 14
- Citations by year
- 2026: 157 · 2025: 293 · 2024: 211 · 2023: 184 · 2022: 198 · 2021: 157 · 2020: 121 · 2019: 106 · 2018: 66 · 2017: 52 · 2016: 56 · 2015: 43 · 2014: 46 · 2013: 28 · 2012: 17
- FWCI
- 14.24
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Disease and Adiposity
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- visceral adiposity index, visceral fat, waist circumference, body mass index, triglycerides, HDL cholesterol, metabolic syndrome, cardiovascular risk, cerebrovascular risk, insulin sensitivity, cardiometabolic risk
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Female, Humans, Cholesterol, HDL, Male, Middle Aged, Risk Factors, Triglycerides, Body Mass Index, Logistic Models, Intra-Abdominal Fat, Waist Circumference, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.